Acquisition Synergy Leverage Zoetis ownership to access the veterinary distribution network and accelerate adoption of Basepaws tests. Align Basepaws precision health offerings with Zoetis product roadmaps to create bundled solutions for clinics and pet owners.

Direct Consumer Growth Capitalize on Basepaws direct to consumer dog tests and multichannel reach to drive cross sells with existing cat tests and upcoming microbiome panels. Explore subscription models and education focused campaigns to convert pet owners.

Vet Tools Expansion Market the veterinary genetic and oral microbiome screening tools to clinics as repeatable diagnostic panels. Integrate with veterinary practice management and telehealth partners to broaden adoption and create recurring revenue.

Microbiome Advantage Highlight the combined genetic and microbiome data approach as a differentiator in pet health intelligence. Seek research collaborations and pharma and biotech partnerships to develop additional screening panels and preventive care insights.

Growth Readiness With solid traction and the backing of a major acquirer, pursue regional expansion and channel diversification, targeting veterinary networks, pet retailers, and digital health platforms to scale sales and partnerships.